substance p has been researched along with Respiratory Syncytial Virus Infections in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (91.67) | 29.6817 |
2010's | 1 (8.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bermudez, J; Espina, LM; Giuffrida, M; Gotera, J; Maldonado, M; Mavarez, A; Mosquera, J; Pons, H; Valero, N | 1 |
Anderson, LJ; Barskey, A; Goss, L; Tripp, RA | 1 |
Adkins, B; Auais, A; Napchan, G; Piedimonte, G | 1 |
Piedimonte, G | 2 |
Graham, BS; Johnson, TR | 1 |
Balhorn, A; Dakhama, A; El Gazzar, M; Gelfand, EW; Joetham, A; Kanehiro, A; Kodama, T; Larsen, GL; Loader, JE; Miyahara, N; Park, JW; Takeda, K; Taube, C | 1 |
Goldbart, AD; Goldman, JL; Gozal, D; Kheirandish-Gozal, L; Mager, E; Piedimonte, G; Serpero, LD; Veling, MC | 1 |
Booth, JA; Correia, JB; Dankert, HM; Ebrahimi, B; Hart, CA; Semple, MG; Smyth, RL; Stewart, JP | 1 |
Anderson, LJ; Moore, D; Tripp, RA; Winter, J | 1 |
Hu, C; Jiang, X; King, KA; Piedimonte, G; Rodriguez, MM; Romaguera, R | 1 |
Anderson, LJ; Haynes, LM; Tonkin, J; Tripp, RA | 1 |
3 review(s) available for substance p and Respiratory Syncytial Virus Infections
Article | Year |
---|---|
Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection.
Topics: Animals; Asthma; Capillary Permeability; Child; Child, Preschool; Disease Models, Animal; Humans; Infant; Infant, Newborn; Lung; Muscle, Smooth; Nerve Growth Factors; Neuronal Plasticity; Pneumonia; Rats; Receptors, Neurokinin-1; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Risk Factors; Substance P; T-Lymphocytes | 2003 |
Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
Topics: Animals; Antigens, Viral; Disease Models, Animal; Epitopes; Female; Glycoproteins; Immunity; Immunization; Interleukin-4; Interleukin-8; Male; Mice; Mice, Inbred BALB C; Pulmonary Eosinophilia; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Sensitivity and Specificity; Severity of Illness Index; Substance P; Viral Vaccines | 2004 |
Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Bronchiolitis, Viral; Humans; Models, Immunological; Neural Pathways; Neuroimmunomodulation; Palivizumab; Respiratory Syncytial Virus Infections; Respiratory System; Substance P | 2001 |
9 other study(ies) available for substance p and Respiratory Syncytial Virus Infections
Article | Year |
---|---|
Respiratory syncytial virus infection increases regulated on activation normal T cell expressed and secreted and monocyte chemotactic protein 1 levels in serum of patients with asthma and in human monocyte cultures.
Topics: Adult; Aged; Asthma; Cells, Cultured; Chemokine CCL2; Chemokine CCL5; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lymphocyte Activation; Male; Middle Aged; Monocytes; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Substance P; T-Lymphocytes; Up-Regulation | 2012 |
Substance P receptor expression on lymphocytes is associated with the immune response to respiratory syncytial virus infection.
Topics: Animals; Antibody Specificity; Antigens, CD; Antigens, Surface; CD8-Positive T-Lymphocytes; Chemotaxis, Leukocyte; Cytokines; Female; Gene Expression Regulation; Leukosialin; Ligands; Lung; Mice; Mice, Inbred BALB C; Parainfluenza Virus 3, Human; Protein Binding; Receptors, Neurokinin-1; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respirovirus Infections; Sialoglycoproteins; Substance P; T-Lymphocytes; Th1 Cells; Th2 Cells | 2002 |
Immunomodulatory effects of sensory nerves during respiratory syncytial virus infection in rats.
Topics: Adjuvants, Immunologic; Animals; Asthma; Leukocyte Count; Lung; Lymphocyte Subsets; Male; Monocytes; Neurokinin-1 Receptor Antagonists; Neurons, Afferent; Piperidines; Pneumonia, Viral; Rats; Rats, Inbred F344; Receptors, Neurokinin-1; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Specific Pathogen-Free Organisms; Substance P | 2003 |
Alteration of airway neuropeptide expression and development of airway hyperresponsiveness following respiratory syncytial virus infection.
Topics: Animals; Antiemetics; Calcitonin Gene-Related Peptide; Humans; Inflammation; Lung; Mice; Mice, Inbred BALB C; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Pyrrolidonecarboxylic Acid; Respiratory Hypersensitivity; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Substance P | 2005 |
Neurotrophins and tonsillar hypertrophy in children with obstructive sleep apnea.
Topics: Adenoids; Brain-Derived Neurotrophic Factor; Child; Child, Preschool; Female; Humans; Hypertrophy; Male; Nerve Growth Factor; Nerve Growth Factors; Palatine Tonsil; Receptor, trkA; Receptors, Neurokinin-1; Respiratory Syncytial Virus Infections; RNA, Messenger; Sleep Apnea, Obstructive; Substance P; Tonsillitis | 2007 |
Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon gamma and substance P.
Topics: Bronchiolitis; Female; Humans; Immunity, Innate; Infant; Infant, Newborn; Interferon-gamma; Interleukin-9; Male; Oxygen; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory System; Substance P; Urea | 2007 |
Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.
Topics: Animals; Antigens, Viral; Bronchiolitis; Bronchoalveolar Lavage; CD3 Complex; Chlorocebus aethiops; Cytokines; Female; HN Protein; Humans; Mice; Mice, Inbred BALB C; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Substance P; T-Lymphocytes; Vero Cells; Viral Envelope Proteins; Viral Proteins | 2000 |
Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats.
Topics: Animals; Antibodies, Monoclonal; Body Weight; Cell Line; DNA Primers; Humans; Immunoenzyme Techniques; Lung; Neurogenic Inflammation; Neuropeptides; Piperidines; Rats; Rats, Inbred F344; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Receptors, Vasoactive Intestinal Peptide; Respiratory Syncytial Virus Infections; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substance P; Up-Regulation | 2001 |
Neutralizing anti-F glycoprotein and anti-substance P antibody treatment effectively reduces infection and inflammation associated with respiratory syncytial virus infection.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Viral; Cytokines; Female; Inflammation; Lung; Mice; Mice, Inbred BALB C; Neutralization Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Substance P; Treatment Outcome; Viral Proteins; Virus Replication | 2002 |